Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function [Phase 1]

View source ↗

Summary

Phase 1 study reporting pharmacokinetics and pharmacodynamics of cilofexor in adults with normal and impaired hepatic function; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis
• Sclerosing Cholangitis

Drugs mentioned

• Cilofexor (cilofexor)

Snippet

Sponsor: Gilead Sciences | Conditions: Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC) | Phase 1 | Status: COMPLETED | Results posted: 2020-09-30